გამოგვყევი
GE
GE

Life4me+-ის ერთ-ერთი მთავარი მიზანია აივ, სხვა სგგი, ჰეპატიტი C და ტუბერკულოზის ახალი შემთხვევების პრევენცია.

აპლიკაცია ეხმარება აივ დადებით პირებს ექიმებთან ანონიმური კომუნიკაციის დამყარებაში. ეს ყველაფერი დაგეხმარებათ ორგანიზება გაუკეთოთ მედიკამენტების მიღების განრიგს და დააყენოთ ფარული და პერსონალიზებული შეხსენებები.

ყველა სიახლე

არქივი

✕
18 მარტი 2019
7763
The effectiveness of doravirine in combination with other ARVTs is not inferior to DRV + r / EFV

The effectiveness of doravirine in combination with other ARVTs is not inferior to DRV + r / EFV

#ART drug doravirin (DOR) as part of a 3-component therapy regimen HIV-1 is comparable in effectiveness to the combination of darunavir plus ritonavir (DRV + r) and efavirenza (EFV), follows from preliminary results of two ongoing clinical phase studies III DRIVE-FORWARD ...
17 მარტი 2019
9409
TAF as PrEP: is efficiency a matter of form?

TAF as PrEP: is efficiency a matter of form?

Two studies of experimental pre-exposure prophylaxis schemes for HIV infection (PrEP) using the drug tenofovir alafenamide (TAF) immediately confirmed the effectiveness of therapy, but yielded conflicting results. According to experts who presented data at the Conference ...
16 მარტი 2019
10609
On CROI were presented the latest data of the effectiveness and safety of fostemsavir

On CROI were presented the latest data of the effectiveness and safety of fostemsavir

On CROI were presented the latest information on studies of fostemsavir, a drug for the treatment of HIV infection of a fundamentally new type. Fostemsavir (FTR) is the first in its class prodrug of the Temsavir attachment inhibitor (TMR). TMR binds to HIV-1 by blocking ...
15 მარტი 2019
8535
One in six South Africans has potential viral resistance to ART

One in six South Africans has potential viral resistance to ART

At the Conference on Retroviruses and Opportunistic Infections (CROI2019), was announced that up to 17% of South African people who had not previously been treated and who had evaded testing for HIV could have a drug-resistant strain of the virus, and more than half of those ...
14 მარტი 2019
8819
MK-8591 implant has been shown to be highly effective at low dosages

MK-8591 implant has been shown to be highly effective at low dosages

#Merck's nucleoside reverse transcriptase translocation inhibitor (NRTTI) MK-8591 (outside the US and Canada - MSD) showed high antiviral activity against HIV-1 with a single dose of 0.5 mg, follows from preliminary results of clinical phase II trials (NCT03272347) presented ...
13 მარტი 2019
8608
Second Generation HIV Maturation Inhibitor Presented in USA

Second Generation HIV Maturation Inhibitor Presented in USA

Dr. Edwin De Jesus of the Orlandian Center for Immunology (USA) last week presented the results of a phase IIa clinical trial of an innovative second-generation HIV maturation inhibitor GSK2838232. The drug, which previously demonstrated a clearly defined preclinical virological ...
12 მარტი 2019
9628
Gilead presented data on the safety of its long-acting ARV drug

Gilead presented data on the safety of its long-acting ARV drug

Last Thursday, March 7, on the closing day of the International Conference on Retroviruses and Opportunistic Infections (CROI2019), the first data on the safety and tolerability of a fundamentally new ART-medication of prolonged action GS-6207 were presented. The development ...
9 მარტი 2019
9657
Mortality from breast cancer is more common among women with HIV

Mortality from breast cancer is more common among women with HIV

According to a cohort study presented at the Conference on Retroviruses and Opportunistic Infections (CROI2019) in Seattle, the mortality rate among HIV-positive women with breast cancer (BC) is higher than among those with a negative status.
8 მარტი 2019
8987
Test and Treat Principle Reduces the Number of New HIV Cases in South Africa by 30%

Test and Treat Principle Reduces the Number of New HIV Cases in South Africa by 30%

According to the latest data presented at the Conference on Retroviruses and Opportunistic Infections (CROI2019), the number of new HIV infections in southern Africa can be significantly reduced by voluntary testing for HIV in communities and immediately sending to treatment ...
8 მარტი 2019
8256
HIV-specific broadly neutralizing antibodies are promising

HIV-specific broadly neutralizing antibodies are promising

#ART has revolutionized the treatment and prevention of HIV infection. However, a violation of the systemic nature of medication use today will almost certainly lead to an increase in viral load. The reason for this is the existence of hidden "tanks". Knowing this, scientists ...
ჩვენ ვიყენებთ ქუქის, რათა გავაუმჯობესოთ თქვენ მიერ საიტის მოხმარება
ვებ-გვერდზე ნებისმიერ ღილაკზე დაჭერით თქვენ გვაძლევთ უფლებას, რომ გამოვიყენოთ თქვენი cookies.